Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping

(2017) Adriana C. Vidal et al.   EUROPEAN UROLOGY

Is Body Mass Index the Best Adiposity Measure for Prostate Cancer Risk? Results From a Veterans Affairs Biopsy Cohort

(2017) Lourdes Guerrios-Rivera et al.   UROLOGY

Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?

(2016) L E Howard et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

(2016) A C Vidal et al.   PROSTATE CANCER AND PROSTATIC DISEASES

The Obesity Paradox in Cancer: a Review

(2016) Hannah Lennon et al.   Current Oncology Reports

Obesity Increases the Risk for High-Grade Prostate Cancer: Results from the REDUCE Study

(2014) A. C. Vidal et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prostate cancer incidence, clinical stage and survival in relation to obesity: A prospective cohort study in Denmark

(2014) Henrik Møller et al.   INTERNATIONAL JOURNAL OF CANCER

Obesity and Long-Term Survival after Radical Prostatectomy

(2014) Heather J. Chalfin et al.   JOURNAL OF UROLOGY

Body mass index and incidence of localized and advanced prostate cancer—a dose–response meta-analysis of prospective studies

(2012) A. Discacciati et al.   ANNALS OF ONCOLOGY

End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice

(2011) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY

A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

(2010) Howard S. Kim et al.   BJU INTERNATIONAL

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer

(2010) Bruce Montgomery et al.   BMC CANCER

The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer

(2008) A J Armstrong et al.   PROSTATE CANCER AND PROSTATIC DISEASES